HIPAA Journal

DECEMBER 22, 2022

The 4,155-page bill includes many healthcare provisions that will help hospitals and health systems provide better care for patients. billion in funding for the Department of Health and Human Services, increasing HHS funds by a further $9.9 The bill proposes $120.7 billion from last year.

FDA 117

FDA COVID-19 Governance Medicaid 117

Healthcare Law Today

NOVEMBER 9, 2022

Starting January 1, 2023, Medicare will cover telehealth-based treatment services delivered by federally-accredited opioid treatment programs (OTPs), commonly referred to as “methadone clinics.” Background and History of Medicare Telehealth Coverage of SUD Treatment. New Changes to Medicare OTP Telehealth Services.

Medicare 52

Medicare Medicare COVID-19 Telemedicine 52

Healthcare Law Blog

MARCH 20, 2023

7] In alignment with this initiative, the Centers for Medicare and Medicaid Services (CMS) has recently issued a proposed rule to streamline the prior authorization process, which would purportedly decrease processing times from twenty-one (21) to seven (7) days. 2022 COVID-19 Practitioner Impact Survey. November 2022. [2]

Medicaid 52

Medicaid Medicaid Licensing ACA 52

Health Law Advisor

MARCH 7, 2023

Telemedicine Prescribing During the COVID-19 PHE During the COVID-19 PHE, among many other regulatory flexibilities, federal and state prescribing requirements were relaxed. This deadline came and went, also without meaningful action taken by DEA. 21 U.S.C. § 802(17).

Telemedicine 52

Telemedicine COVID-19 FDA Compliance 52

Healthcare Law Blog

JANUARY 6, 2023

In addition to funding, the Act modifies certain telehealth provisions, expands and extends components of the Medicare and Medicaid programs, and supports initiatives within the behavioral health and substance use treatment spaces. Medicare Extension & Adjustments. The Act provides for nearly $1.7 Extension of Key Programs.

COVID-19 52

COVID-19 Medicaid Medicaid COVID-19 Vaccine 52

C&M Health Law

JANUARY 25, 2023

Notably, the Act neither fulfilled the Biden Administration’s request for additional COVID-19 response funding nor included the Verifying Accurate Leading-edge In Vitro Clinical Test (IVCT) Development (VALID) Act, which proposed updating the current diagnostic testing regulatory framework.

Medicaid 104

Medicaid Medicaid Medicare Medicare 104

HIPAA Journal

JANUARY 9, 2023

In November 2022, OCR and the Substance Abuse and Mental Health Services Administration (SAMHSA) issued a Notice of Proposed Rulemaking (NPRM) which sees both Part 2 and HIPAA changes to better align these regulations. HIPAA Changes Due to the 2019 Novel Coronavirus (SARS-CoV-2) and COVID-19.

HIPAA 111

HIPAA COVID-19 COVID-19 Vaccine Compliance 111